Skip to content
ClinCalc Pro
Menu
Non-Opioid Analgesic / Antipyretic — IV

Paracetamol (IV)

Brand names: Perfalgan

Intravenous paracetamol is a non-opioid analgesic and antipyretic used perioperatively as a baseline component of multimodal analgesia and where the oral route is unavailable.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Paracetamol produces analgesia and antipyresis through centrally mediated mechanisms, including effects on prostaglandin pathways and descending modulation, with minimal peripheral anti-inflammatory action.

Prescribing in practice

  • Dose by body weight and reduce the dose in low body weight, malnutrition, hepatic impairment, chronic alcohol use or dehydration to avoid hepatotoxicity, and guard against accidental overdose by accounting for all paracetamol-containing products.
  • Administer as a controlled infusion and double-check weight-based dosing, as intravenous administration bypasses first-pass metabolism and errors carry greater risk.
  • It is opioid-sparing and combines well with NSAIDs and regional techniques as part of multimodal analgesia.

Monitoring

Routine monitoring is not required at therapeutic doses, but check liver function and consider toxicology if overdose or cumulative excess is suspected.

Counselling the patient

  • This is a paracetamol drip given into a vein to help control pain and reduce reliance on stronger painkillers.
  • Do not take additional paracetamol from other sources without telling staff.

Evidence & guidelines

Intravenous paracetamol is widely used and recommended as a foundation of opioid-sparing multimodal perioperative analgesia.

Reference: Perfalgan SPC; PROSPECT Guidelines; ERAS Society Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.